More cancer success with drugs that enlist immune system

For the first time, a major study shows that a drug targeting the body’s disease-fighting immune system may improve survival for the most common form of lung cancer. These newer kinds of drugs have transformed treatment of melanoma, the deadliest kind of skin cancer.

For the first time, a major study shows that a drug targeting the body’s disease-fighting immune system may improve survival for the most common form of lung cancer. These newer kinds of drugs have transformed treatment of melanoma, the deadliest kind of skin cancer.

SOURCE: Health News – Read entire story here.